Investing Profile

Larry Lasky

InvestorVC
Partner at The Column Group
Photo of Larry Lasky, Partner at The Column Group

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
cb
$100K - $5.0M
$1.5M
14
$600M
CompanyStageDateRound SizeTotal Raised
Eikon Therapeutics
Series DFeb 2025$350M
Series BJan 2022$520M
Series AMay 2021$150M
$1B
Co-investors: Josh Wolfe (Lux Capital), Leon Chen (The Column Group), Adam Goulburn (Dimension Capital), Dror Berman (Innovation Endeavors), Eric Schmidt (Innovation Endeavors)
Accent Therapeutics
Series CJan 2024$75M
Series BApr 2020$63M
Series AMay 2018$40M
$180M
Co-investors: Naveen Krishnan (Leaps by Bayer), Jason Rhodes (Atlas Venture)
Revolution Medicines
Series CJul 2019$100M
Series BApr 2018$56M
Series ADec 2016$25M
$180M
Co-investors: Thilo Schroeder (Nextech Invest)
Cleave Therapeutics
Series ANov 2011$42M
$100M
Co-investors: Carol Gallagher (New Enterprise Associates (NEA)), Robert Garland (New Enterprise Associates (NEA)), Andrew Schwab (5am Ventures), Peter Thompson (OrbiMed), Kush Parmar (5am Ventures), Marc Singer (Osage University Partners), Alfred Scheidegger (Nextech Invest)
Calithera Biosciences
Series UnknownNov 2011$4M
Series AJul 2010$40M
$81M
Co-investors: Jean George (Advanced Technology Ventures), Ralph (Chris) Christoffersen (Morgenthaler Ventures), Christoph Westphal (Longwood Fund)
OncoMed Pharmaceuticals
Series BNov 2008$150M
Series ASep 2005$14M
$170M
Co-investors: Jonathan Root (U.S. Venture Partners (USVP))